Cite
HARVARD Citation
Monteleone, G. et al. (2016). Impact of patient characteristics on the clinical efficacy of mongersen (GED‐0301), an oral Smad7 antisense oligonucleotide, in active Crohn's disease. Alimentary pharmacology & therapeutics. 43 (6), pp. 717-724. [Online].